Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Chung

Showing results (191-200 of 237) with videos related to

Pageof 24
Sort By:
BJU International|May 5, 2018
Gene expression signatures prognostic for relapse in stage I testicular germ cell tumoursJeremy Lewin, Laleh Soltan Ghoraie, Philippe L Bedard, et al.
Annals of Surgical Oncology|November 18, 2024
Identification of Malignancy in Peritumoral Edema in Soft Tissue Sarcoma: A Novel Targeted Molecular ApproachMiguel Alfonso V Principe, Nalan Gokgoz, Patrick Prochazka, et al.
Therapeutic Advances in Medical Oncology|October 2, 2023
Clinico-demographic characteristics and outcomes of radiation-induced sarcomas (RIS): a CanSaRCC studyMauricio Fernando Ribeiro, Hagit Peretz Soroka, Zainab Bhura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2024
Hypofractionated Preoperative Radiation Should Not Yet Be Used as Standard of Care for Extremity and Truncal Soft Tissue SarcomaElizabeth H Baldini, B Ashleigh Guadagnolo, Kilian E Salerno, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 23, 2020
Controversies in the management of clinical stage 1 testis cancerGregory J Nason, Peter Chung, Padraig Warde, et al.
Frontiers in Oncology|September 12, 2022
MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancerCynthia Ménard, Inmaculada Navarro-Domenech, Zhihu Amy Liu, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 16, 2016
The initiation of a multidisciplinary bladder cancer clinic and the uptake of neoadjuvant chemotherapy: A time-series analysisMadhur Nayan, Bimal Bhindi, Julie L Yu, et al.
Advances in Radiation Oncology|February 1, 2021
Utilization of Salvage and Systemic Therapies for Recurrent Prostate Cancer as a Result of <sup>18</sup>F-DCFPyL PET/CT RestagingWei Liu, Katherine Zukotynski, Louise Emmett, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 2, 2020
Clinical dilemmas in local and regional testis cancerGregory J Nason, Ricardo A Rendon, Lori Wood, et al.
Frontiers in Oncology|December 5, 2022
Corrigendum: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancerCynthia Ménard, Inmaculada Navarro-Domenech, Zhihu Amy Liu, et al.
Pageof 24

Showing results (191-200 of 237) with videos related to

Sort By:
Pageof 24
BJU International|May 5, 2018
Gene expression signatures prognostic for relapse in stage I testicular germ cell tumoursJeremy Lewin, Laleh Soltan Ghoraie, Philippe L Bedard, et al.
Annals of Surgical Oncology|November 18, 2024
Identification of Malignancy in Peritumoral Edema in Soft Tissue Sarcoma: A Novel Targeted Molecular ApproachMiguel Alfonso V Principe, Nalan Gokgoz, Patrick Prochazka, et al.
Therapeutic Advances in Medical Oncology|October 2, 2023
Clinico-demographic characteristics and outcomes of radiation-induced sarcomas (RIS): a CanSaRCC studyMauricio Fernando Ribeiro, Hagit Peretz Soroka, Zainab Bhura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2024
Hypofractionated Preoperative Radiation Should Not Yet Be Used as Standard of Care for Extremity and Truncal Soft Tissue SarcomaElizabeth H Baldini, B Ashleigh Guadagnolo, Kilian E Salerno, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 23, 2020
Controversies in the management of clinical stage 1 testis cancerGregory J Nason, Peter Chung, Padraig Warde, et al.
Frontiers in Oncology|September 12, 2022
MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancerCynthia Ménard, Inmaculada Navarro-Domenech, Zhihu Amy Liu, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 16, 2016
The initiation of a multidisciplinary bladder cancer clinic and the uptake of neoadjuvant chemotherapy: A time-series analysisMadhur Nayan, Bimal Bhindi, Julie L Yu, et al.
Advances in Radiation Oncology|February 1, 2021
Utilization of Salvage and Systemic Therapies for Recurrent Prostate Cancer as a Result of <sup>18</sup>F-DCFPyL PET/CT RestagingWei Liu, Katherine Zukotynski, Louise Emmett, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 2, 2020
Clinical dilemmas in local and regional testis cancerGregory J Nason, Ricardo A Rendon, Lori Wood, et al.
Frontiers in Oncology|December 5, 2022
Corrigendum: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancerCynthia Ménard, Inmaculada Navarro-Domenech, Zhihu Amy Liu, et al.
Pageof 24